The OncoSeq® Cancer Screening range of tests, employs Next Generation Sequencing technology to identify genetic variants associated with hereditary cancer risk.
OncoSeq® offers a choice of tests to allow patients and healthcare providers to choose from the most common genes involved in cancer link like BRCA1 and BRCA2, to the most comprehensive hereditary cancer screening panel with 50 genes that have been reported to be associated with increased risk of developing cancer.
OncoSeq® helps identifying higher risk individuals, as well as understand the genetic roots of cancer for patients, making it possible to take preventative actions to avoid recurrence and prevent occurrence of cancer, unlike screening methodologies like Mammography, PSA testing and others, OncoSeq® truly contributes to the prevention of cancer, rather than early detection.
The OncoSeq® range covers almost all cancers that may have a genetic risk factor, this includes Breast, ovarian, Prostate, Colon and many others.
The OncoSeq® range of cancer screening tests comes with optional clinical genetic counseling to help individuals understand if this test is right for them and help tested subjects understand their test results and how to deal with them.
OncoSeq® is the right step on the path of cancer prevention.